QYR Market Research Global Medical Asparaginase market research | Page 3

QYResearch
• Asparaginase is an enzyme, as a medication it is used to treat acute
lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-
Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under
the skin. A pegylated version is also available.
• Asparaginase was approved for medical use in the United States in 1978.
It is on the World Health Organization's List of Essential Medicines, the
most effective and safe medicines needed in a health system.
www.qyresearch.com